Pharmaceutical Desiccants Market Research Reportβ€”Global Forecast till 2030

Pharmaceutical Desiccants Market Research Report Information By Type Silica Gel, Activated, Carbonclay, Molecular Sieves) End Use (Tablets, API's, Crbonclay Desiccant, Molecular Sieves) Forecast Till 2030

ID: MRFR/CnM/2838-CR | April 2022 | Region: Global | 185 Pages         

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 14

1.1 MARKET ATTRACTIVENESS ANALYSIS 16

1.1.1 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY TYPE 17

1.1.2 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY END USE 18

1.1.3 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY REGION 19

2 MARKET INTRODUCTION 20

2.1 DEFINITION 20

2.2 SCOPE OF THE STUDY 20

2.3 MARKET STRUCTURE 20

3 RESEARCH METHODOLOGY 21

3.1 RESEARCH PROCESS 21

3.2 PRIMARY RESEARCH 22

3.3 SECONDARY RESEARCH 23

3.4 MARKET SIZE ESTIMATION 23

3.5 TOP-DOWN AND BOTTOM-UP APPROACH 24

3.6 FORECAST MODEL 25

3.7 LIST OF ASSUMPTIONS & LIMITATIONS 26

4 MARKET DYNAMICS 27

4.1 OVERVIEW 27

4.2 DRIVERS 28

4.2.1 GROWING GERIATRIC POPULATION ACROSS THE GLOBE 28

4.2.2 EXPANDING PHARMACEUTICAL INDUSTRY 28

4.2.3 GROWTH OF THE PACKAGING INDUSTRY 29

4.3 RESTRAINTS 30

4.3.1 STRINGENT REGULATIONS AND HIGH COST OF THE FINISHED PRODUCT 30

4.4 OPPORTUNITIES 31

4.4.1 INCREASING DEMAND FOR PHARMACEUTICAL DESICCANTS IN EMERGING ECONOMIES 31

4.5 CHALLENGE 31

4.5.1 RISING CUSTOMER EXPECTATIONS IN THE INDIAN MARKET 31

5 MARKET FACTOR ANALYSIS 32

5.1 SUPPLY CHAIN ANALYSIS 32

5.1.1 RAW MATERIALS SUPPLIERS 32

5.1.2 PHARMACEUTICALS DESICCANTS MANUFACTURERS 32

5.1.3 DISTRIBUTION CHANNEL 32

5.1.4 END-USE INDUSTRIES 33

5.2 PORTER’S FIVE FORCES MODEL 33

5.2.1 THREAT OF NEW ENTRANTS 34

5.2.2 INTENSITY OF COMPETITIVE RIVALRY 34

5.2.3 THREAT OF SUBSTITUTES 34

5.2.4 BARGAINING POWER OF SUPPLIERS 34

5.2.5 BARGAINING POWER OF BUYERS 35

5.3 IMPACT OF COVID-19 ON PHARMACEUTICAL DESICCANTS MARKET 35

5.3.1 OVERVIEW 35

5.3.2 IMPACT ON SUPPLY CHAIN 35

5.3.3 QUALITATIVE ANALYSIS ON CHANGE IN DEMAND FROM END USERS 35

6 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY TYPE 36

6.1 OVERVIEW 36

6.1.1 PHARMACEUTICAL DESICCANTS: MARKET ESTIMATES & FORECAST BY TYPE, 2019–2030 36

6.1.2 PHARMACEUTICAL DESICCANTS: MARKET ESTIMATES & FORECAST BY TYPE, 2019–2030 37

6.2 SILICA GEL 38

6.2.1 SILICA GEL: MARKET ESTIMATES & FORECAST BY REGION,2019–2030 38

6.3 ACTIVATED 39

6.3.1 ACTIVATED: MARKET ESTIMATES & FORECAST BY REGION,2019–2030 39

6.4 CARBONCLAY DESICCANT 40

6.4.1 CARBONCLAY DESICCANT: MARKET ESTIMATES & FORECAST BY REGION,2019–2030 40

6.5 MOLECULAR SIEVES 41

6.5.1 MOLECULAR SIEVES: MARKET ESTIMATES & FORECAST BY REGION,2019–2030 41

7 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY END-USE 42

7.1 OVERVIEW 42

7.1.1 PHARMACEUTICAL DESICCANTS: MARKET ESTIMATES & FORECAST BY END-USE, 2019–2030 42

7.1.2 PHARMACEUTICAL DESICCANTS: MARKET ESTIMATES & FORECAST BY END-USE, 2019–2030 43

7.2 TABLETS 44

7.2.1 TABLETS: MARKET ESTIMATES & FORECAST BY REGION,2019–2030 44

7.3 API’S 45

7.3.1 API’S: MARKET ESTIMATES & FORECAST BY REGION,2019–2030 45

7.4 CAPSULES 46

7.4.1 CAPSULES: MARKET ESTIMATES & FORECAST BY REGION,2019–2030 46

7.5 NUTRACEUTICAL PRODUCT PACKAGING 47

7.5.1 NUTRACEUTICAL PRODUCT PACKAGING: MARKET ESTIMATES & FORECAST BY REGION,2019–2030 47

8 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY REGION 49

8.1 OVERVIEW 49

8.2 NORTH AMERICA 52

8.2.1 US 55

8.2.2 CANADA 57

8.3 EUROPE 59

8.3.1 GERMANY 62

8.3.2 UK 64

8.3.3 FRANCE 66

8.3.4 SPAIN 68

8.3.5 ITALY 70

8.3.6 RUSSIA 72

8.3.7 POLAND 74

8.3.8 REST OF EUROPE 76

8.4 ASIA-PACIFIC 79

8.4.1 CHINA 82

8.4.2 JAPAN 84

8.4.3 INDIA 86

8.4.4 SOUTH KOREA 88

8.4.5 REST OF ASIA-PACIFIC 90

8.5 LATIN AMERICA 93

8.5.1 BRAZIL 96

8.5.2 MEXICO 98

8.5.3 ARGENTINA 100

8.5.4 REST OF LATIN AMERICA 102

8.6 MIDDLE EAST & AFRICA 105

8.6.1 GCC COUNTRIES 108

8.6.2 SOUTH AFRICA 110

8.6.3 TURKEY 112

8.6.4 REST OF THE MIDDLE EAST & AFRICA 114

9 COMPETITIVE LANDSCAPE 117

9.1 INTRODUCTION 117

9.2 MARKET STRATEGY ANALYSIS 117

9.3 KEY DEVELOPMENTS & GROWTH STRATEGIES 118

9.4 COMPETITIVE BENCHMARKING 119

10 COMPANY PROFILES 120

10.1 DUPONT DE NEMOURS, INC. 120

10.1.1 COMPANY OVERVIEW 120

10.1.2 FINANCIAL OVERVIEW 121

10.1.3 PRODUCTS OFFERED 121

10.1.4 KEY DEVELOPMENTS 122

10.1.5 SWOT ANALYSIS 122

10.1.6 KEY STRATEGIES 122

10.2 FILTRATION GROUP CORPORATION 123

10.2.1 COMPANY OVERVIEW 123

10.2.2 FINANCIAL OVERVIEW 123

10.2.3 PRODUCTS OFFERED 123

10.2.4 KEY DEVELOPMENTS 124

10.2.5 SWOT ANALYSIS 124

10.2.6 KEY STRATEGIES 125

10.3 SANNER GMBH 126

10.3.1 COMPANY OVERVIEW 126

10.3.2 FINANCIAL OVERVIEW 126

10.3.3 PRODUCTS OFFERED 126

10.3.4 KEY DEVELOPMENTS 126

10.3.5 SWOT ANALYSIS 127

10.3.6 KEY STRATEGIES 127

10.4 CLARIANT 128

10.4.1 COMPANY OVERVIEW 128

10.4.2 FINANCIAL OVERVIEW 129

10.4.3 PRODUCTS OFFERED 130

10.4.4 KEY DEVELOPMENTS 130

10.4.5 SWOT ANALYSIS 131

10.4.6 KEY STRATEGIES 131

10.5 CSP TECHNOLOGIES, INC. 132

10.5.1 COMPANY OVERVIEW 132

10.5.2 FINANCIAL OVERVIEW 132

10.5.3 PRODUCTS OFFERED 132

10.5.4 KEY DEVELOPMENTS 133

10.5.5 SWOT ANALYSIS 133

10.5.6 KEY STRATEGIES 134

10.6 CAPITOL SCIENTIFIC, INC. 135

10.6.1 COMPANY OVERVIEW 135

10.6.2 FINANCIAL OVERVIEW 135

10.6.3 PRODUCTS OFFERED 135

10.6.4 KEY DEVELOPMENTS 135

10.6.5 SWOT ANALYSIS 136

10.6.6 KEY STRATEGIES 136

10.7 DESICCARE, INC. 137

10.7.1 COMPANY OVERVIEW 137

10.7.2 FINANCIAL OVERVIEW 137

10.7.3 PRODUCTS OFFERED 137

10.7.4 KEY DEVELOPMENTS 137

10.7.5 SWOT ANALYSIS 138

10.7.6 KEY STRATEGIES 138

10.8 W. R. GRACE & CO 139

10.8.1 COMPANY OVERVIEW 139

10.8.2 FINANCIAL OVERVIEW 139

10.8.3 PRODUCTS OFFERED 140

10.8.4 KEY DEVELOPMENTS 140

10.8.5 SWOT ANALYSIS 140

10.8.6 KEY STRATEGIES 141

10.9 DESICAN INC. 142

10.9.1 COMPANY OVERVIEW 142

10.9.2 FINANCIAL OVERVIEW 142

10.9.3 PRODUCTS OFFERED 142

10.9.4 KEY DEVELOPMENTS 142

10.9.5 SWOT ANALYSIS 143

10.9.6 KEY STRATEGIES 143

10.10 OKER-CHEMIE GMBH 144

10.10.1 COMPANY OVERVIEW 144

10.10.2 FINANCIAL OVERVIEW 144

10.10.3 PRODUCTS OFFERED 144

10.10.4 KEY DEVELOPMENTS 144

10.10.5 SWOT ANALYSIS 145

10.10.6 KEY STRATEGIES 145

11 APPENDIX 146

11.1 REFERENCES 146

11.2 RELATED REPORTS 147

 

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 26

TABLE 2 PHARMACEUTICAL DESICCANTS MARKET ESTIMATES & FORECAST, BY TYPE, 2019–2030 (USD THOUSAND) 36

TABLE 3 PHARMACEUTICAL DESICCANTS MARKET ESTIMATES & FORECAST, BY TYPE, 2019–2030 (TONS) 37

TABLE 4 SILICA GEL MARKET ESTIMATES & FORECAST, BY REGION, 2019–2030 (USD THOUSAND) 38

TABLE 5 SILICA GEL MARKET ESTIMATES & FORECAST, BY REGION, 2019–2030 (TONS) 38

TABLE 6 ACTIVATED MARKET ESTIMATES & FORECAST, BY REGION, 2019–2030 (USD THOUSAND) 39

TABLE 7 ACTIVATED MARKET ESTIMATES & FORECAST, BY REGION, 2019–2030 (TONS) 39

TABLE 8 CARBONCLAY DESICCANT MARKET ESTIMATES & FORECAST, BY REGION, 2019–2030 (USD THOUSAND) 40

TABLE 9 CARBONCLAY DESICCANT MARKET ESTIMATES & FORECAST, BY REGION, 2019–2030 (TONS) 40

TABLE 10 MOLECULAR SIEVES MARKET ESTIMATES & FORECAST, BY REGION, 2019–2030 (USD THOUSAND) 41

TABLE 11 MOLECULAR SIEVES MARKET ESTIMATES & FORECAST, BY REGION, 2019–2030 (TONS) 41

TABLE 12 PHARMACEUTICAL DESICCANTS MARKET ESTIMATES & FORECAST, BY END-USE, 2019–2030 (USD THOUSAND) 42

TABLE 13 PHARMACEUTICAL DESICCANTS MARKET ESTIMATES & FORECAST, BY END-USE, 2019–2030 (TONS) 43

TABLE 14 TABLETS MARKET ESTIMATES & FORECAST, BY REGION, 2019–2030 (USD THOUSAND) 44

TABLE 15 TABLETS MARKET ESTIMATES & FORECAST, BY REGION, 2019–2030 (TONS) 44

TABLE 16 API’S MARKET ESTIMATES & FORECAST, BY REGION, 2019–2030 (USD THOUSAND) 45

TABLE 17 API’S MARKET ESTIMATES & FORECAST, BY REGION, 2019–2030 (TONS) 45

TABLE 18 CAPSULES MARKET ESTIMATES & FORECAST, BY REGION, 2019–2030 (USD THOUSAND) 46

TABLE 19 CAPSULES MARKET ESTIMATES & FORECAST, BY REGION, 2019–2030 (TONS) 46

TABLE 20 NUTRACEUTICAL PRODUCT PACKAGING MARKET ESTIMATES & FORECAST, BY REGION, 2019–2030 (USD THOUSAND) 47

TABLE 21 NUTRACEUTICAL PRODUCT PACKAGING MARKET ESTIMATES & FORECAST, BY REGION, 2019–2030 (TONS) 48

TABLE 22 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY REGION, 2019–2030 (USD THOUSAND) 50

TABLE 23 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY REGION, 2019–2030 (TONS) 51

TABLE 24 NORTH AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY COUNTRY, 2019–2030 (USD THOUSAND) 52

TABLE 25 NORTH AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY COUNTRY, 2019–2030 (TONS) 52

TABLE 26 NORTH AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 53

TABLE 27 NORTH AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 53

TABLE 28 NORTH AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 54

TABLE 29 NORTH AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 54

TABLE 30 US: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 55

TABLE 31 US: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 55

TABLE 32 US: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 56

TABLE 33 US: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 56

TABLE 34 CANADA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 57

TABLE 35 CANADA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 57

TABLE 36 CANADA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 58

TABLE 37 CANADA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 58

TABLE 38 EUROPE: PHARMACEUTICAL DESICCANTS MARKET, BY COUNTRY, 2019–2030 (USD THOUSAND) 59

TABLE 39 EUROPE: PHARMACEUTICAL DESICCANTS MARKET, BY COUNTRY, 2019–2030 (TONS) 60

TABLE 40 EUROPE: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 60

TABLE 41 EUROPE: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 61

TABLE 42 EUROPE: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 61

TABLE 43 EUROPE: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 62

TABLE 44 GERMANY: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 62

TABLE 45 GERMANY: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 63

TABLE 46 GERMANY: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 63

TABLE 47 GERMANY: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 64

TABLE 48 UK: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 64

TABLE 49 UK: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 65

TABLE 50 UK: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 65

TABLE 51 UK: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 66

TABLE 52 FRANCE: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 66

TABLE 53 FRANCE: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 67

TABLE 54 FRANCE: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 67

TABLE 55 FRANCE: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 68

TABLE 56 SPAIN: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 68

TABLE 57 SPAIN: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 69

TABLE 58 SPAIN: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 69

TABLE 59 SPAIN: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 70

TABLE 60 ITALY: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 70

TABLE 61 ITALY: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 71

TABLE 62 ITALY: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 71

TABLE 63 ITALY: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 72

TABLE 64 RUSSIA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 72

TABLE 65 RUSSIA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 73

TABLE 66 RUSSIA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 73

TABLE 67 RUSSIA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 74

TABLE 68 POLAND: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 74

TABLE 69 POLAND: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 75

TABLE 70 POLAND: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 75

TABLE 71 POLAND: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 76

TABLE 72 REST OF EUROPE: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 76

TABLE 73 REST OF EUROPE: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 77

TABLE 74 REST OF EUROPE: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 77

TABLE 75 REST OF EUROPE: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 78

TABLE 76 ASIA-PACIFIC: PHARMACEUTICAL DESICCANTS MARKET, BY COUNTRY, 2019–2030 (USD THOUSAND) 79

TABLE 77 ASIA-PACIFIC: PHARMACEUTICAL DESICCANTS MARKET, BY COUNTRY, 2019–2030 (TONS) 80

TABLE 78 ASIA-PACIFIC: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 80

TABLE 79 ASIA-PACIFIC: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 81

TABLE 80 ASIA-PACIFIC: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 81

TABLE 81 ASIA-PACIFIC: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 82

TABLE 82 CHINA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 82

TABLE 83 CHINA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 83

TABLE 84 CHINA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 83

TABLE 85 CHINA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 84

TABLE 86 JAPAN: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 84

TABLE 87 JAPAN: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 85

TABLE 88 JAPAN: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 85

TABLE 89 JAPAN: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 86

TABLE 90 INDIA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 86

TABLE 91 INDIA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 87

TABLE 92 INDIA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 87

TABLE 93 INDIA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 88

TABLE 94 SOUTH KOREA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 88

TABLE 95 SOUTH KOREA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 89

TABLE 96 SOUTH KOREA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 89

TABLE 97 SOUTH KOREA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 90

TABLE 98 REST OF ASIA-PACIFIC: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 90

TABLE 99 REST OF ASIA-PACIFIC: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 91

TABLE 100 REST OF ASIA-PACIFIC: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 91

TABLE 101 REST OF ASIA-PACIFIC: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 92

TABLE 102 LATIN AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY COUNTRY, 2019–2030 (USD THOUSAND) 93

TABLE 103 LATIN AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY COUNTRY, 2019–2030 (TONS) 94

TABLE 104 LATIN AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 94

TABLE 105 LATIN AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 95

TABLE 106 LATIN AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 95

TABLE 107 LATIN AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 96

TABLE 108 BRAZIL: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 96

TABLE 109 BRAZIL: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 97

TABLE 110 BRAZIL: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 97

TABLE 111 BRAZIL: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 98

TABLE 112 MEXICO: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 98

TABLE 113 MEXICO: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 99

TABLE 114 MEXICO: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 99

TABLE 115 MEXICO: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 100

TABLE 116 ARGENTINA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 100

TABLE 117 ARGENTINA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 101

TABLE 118 ARGENTINA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 101

TABLE 119 ARGENTINA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 102

TABLE 120 REST OF LATIN AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 102

TABLE 121 REST OF LATIN AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 103

TABLE 122 REST OF LATIN AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 103

TABLE 123 REST OF LATIN AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 104

TABLE 124 MIDDLE EAST & AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY COUNTRY, 2019–2030 (USD THOUSAND) 105

TABLE 125 MIDDLE EAST & AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY COUNTRY, 2019–2030 (TONS) 106

TABLE 126 MIDDLE EAST & AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 106

TABLE 127 MIDDLE EAST & AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 107

TABLE 128 MIDDLE EAST & AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 107

TABLE 129 MIDDLE EAST & AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 108

TABLE 130 GCC COUNTRIES: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 108

TABLE 131 GCC COUNTRIES: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 109

TABLE 132 GCC COUNTRIES: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 109

TABLE 133 GCC COUNTRIES: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 110

TABLE 134 SOUTH AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 110

TABLE 135 SOUTH AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 111

TABLE 136 SOUTH AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 111

TABLE 137 SOUTH AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 112

TABLE 138 TURKEY: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 112

TABLE 139 TURKEY: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 113

TABLE 140 TURKEY: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 113

TABLE 141 TURKEY: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 114

TABLE 142 REST OF THE MIDDLE EAST & AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 114

TABLE 143 REST OF THE MIDDLE EAST & AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019–2030 (TONS) 115

TABLE 144 REST OF THE MIDDLE EAST & AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (USD THOUSAND) 115

TABLE 145 REST OF THE MIDDLE EAST & AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019–2030 (TONS) 116

TABLE 146 KEY DEVELOPMENTS & GROWTH STRATEGIES 118

TABLE 147 DUPONT DE NEMOURS, INC.: PRODUCTS OFFERED 121

TABLE 148 FILTRATION GROUP CORPORATION: PRODUCTS OFFERED 123

TABLE 149 FILTRATION GROUP CORPORATION: KEY DEVELOPMENTS 124

TABLE 150 SANNER GMBH: PRODUCTS OFFERED 126

TABLE 151 SANNER GMBH: KEY DEVELOPMENTS 126

TABLE 152 CLARIANT: PRODUCTS OFFERED 130

TABLE 153 CLARIANT: KEY DEVELOPMENTS 130

TABLE 154 CSP TECHNOLOGIES, INC.: PRODUCTS OFFERED 132

TABLE 155 CSP TECHNOLOGIES, INC.: KEY DEVELOPMENTS 133

TABLE 156 CAPITOL SCIENTIFIC, INC.: PRODUCTS OFFERED 135

TABLE 157 DESICCARE, INC.: PRODUCTS OFFERED 137

TABLE 158 W. R. GRACE & CO: PRODUCTS OFFERED 140

TABLE 159 DESICAN INC.: PRODUCTS OFFERED 142

TABLE 160 OKER-CHEMIE GMBH: PRODUCTS OFFERED 144

 

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 15

FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL PHARMACEUTICAL DESICCANTS MARKET, 2020 16

FIGURE 3 GLOBAL PHARMACEUTICAL DESICCANTS MARKET ANALYSIS, BY TYPE 17

FIGURE 4 GLOBAL PHARMACEUTICAL DESICCANTS MARKET ANALYSIS, BY END USE 18

FIGURE 5 GLOBAL PHARMACEUTICAL DESICCANTS MARKET ANALYSIS, BY REGION 19

FIGURE 6 GLOBAL PHARMACEUTICAL DESICCANTS MARKET: MARKET STRUCTURE 20

FIGURE 7 RESEARCH PROCESS OF MRFR 21

FIGURE 8 MARKET DYNAMICS: ANALYSIS OF THE PHARMACEUTICAL DESICCANTS MARKET 27

FIGURE 9 DRIVER IMPACT ANALYSIS 29

FIGURE 10 RESTRAINT IMPACT ANALYSIS 30

FIGURE 11 SUPPLY CHAIN ANALYSIS 32

FIGURE 12 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL PHARMACEUTICAL DESICCANTS MARKET 33

FIGURE 13 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019 TO 2030 (USD THOUSAND) 36

FIGURE 14 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019 TO 2030 (TONS) 37

FIGURE 15 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019 TO 2030 (USD THOUSAND) 42

FIGURE 16 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019 TO 2030 (TONS) 43

FIGURE 17 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY REGION, 2019–2030 (USD THOUSAND) 50

FIGURE 18 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY REGION, 2019–2030 (TONS) 51

FIGURE 19 NORTH AMERICA: PHARMACEUTICAL DESICCANTS MARKET SHARE, BY COUNTRY, 2020 (% SHARE) 52

FIGURE 20 EUROPE: PHARMACEUTICAL DESICCANTS MARKET SHARE, BY COUNTRY, 2020 (% SHARE) 59

FIGURE 21 ASIA-PACIFIC: PHARMACEUTICAL DESICCANTS MARKET SHARE, BY COUNTRY, 2020 (% SHARE) 79

FIGURE 22 LATIN AMERICA: PHARMACEUTICAL DESICCANTS MARKET SHARE, BY COUNTRY, 2020 (% SHARE) 93

FIGURE 23 MIDDLE EAST & AFRICA: PHARMACEUTICAL DESICCANTS MARKET SHARE, BY COUNTRY, 2020 (% SHARE) 105

FIGURE 24 COMPETITIVE BENCHMARKING 119

FIGURE 25 DUPONT DE NEMOURS, INC.: FINANCIAL OVERVIEW 121

FIGURE 26 DUPONT DE NEMOURS, INC.: SWOT ANALYSIS 122

FIGURE 27 FILTRATION GROUP CORPORATION: SWOT ANALYSIS 124

FIGURE 28 SANNER GMBH: SWOT ANALYSIS 127

FIGURE 29 CLARIANT: FINANCIAL OVERVIEW 129

FIGURE 30 CLARIANT: SWOT ANALYSIS 131

FIGURE 31 CSP TECHNOLOGIES, INC.: SWOT ANALYSIS 133

FIGURE 32 CAPITOL SCIENTIFIC, INC.: SWOT ANALYSIS 136

FIGURE 33 DESICCARE, INC.: SWOT ANALYSIS 138

FIGURE 34 W. R. GRACE & CO: FINANCIAL OVERVIEW SNAPSHOT 139

FIGURE 35 W. R. GRACE & CO: SWOT ANALYSIS 140

FIGURE 36 DESICAN INC.: SWOT ANALYSIS 143

FIGURE 37 OKER-CHEMIE GMBH: SWOT ANALYSIS 145

Pharmaceutical Desiccants Market

The global pharmaceutical desiccants market size was valued at USD 93,167.16 thousand in 2020 and is projected to reach USD 144,840.70 thousand by 2030 at a CAGR of 4.77%

Segmentation

By Type Silica Gel Activated Carbonclay Molecular Sieves
End Use Tablets Api's Crbonclay Desiccant Molecular Sieves

Key Players

  • DuPont de Nemours Inc
  • Filtration Group Corporation
  • Sanner GmBH
  • Clariant
  • Capitol Scientific Inc.
  • Desiccare Inc.
  • W. R. Grace & Co.
  • Desican Inc.
  • Oker-Chemie GmbH

Drivers

  • Expanding Pharmaceutical Industry
  • Growing Geriatric Population Across the Globe
Speak to Analyst Request a Free Sample

Pharmaceutical Desiccants Market Overview


The global pharmaceutical desiccants market size was valued at USD 93,167.16 thousand in 2020 and is projected to reach USD 144,840.70 thousand by 2030 at a CAGR of 4.77%.


A pharmaceutical desiccant is a hygroscopic substance that incites or supports a condition of dryness (drying up) in its surface area; it is the inverse of a humectant. Usually experienced pre-bundled desiccants are solids that assimilate water. Pharmaceutical desiccants are used for specialized purposes which may be in any form other than solid, and sometimes may work on other principles, likewise, for chemical bonding of water molecules. Desiccants are generally used in food products to retain crispness. In the industrial sector, desiccants are majorly used to maintain the level of water in gas streams.


COVID-19 Impact on the Pharmaceutical Desiccants Market:


Different markets across the globe have been impacted by the disruptions that the COVID-19 pandemic has caused. To some extent, the same was observed in the global pharmaceutical desiccants market. This was due to several factors, such as supply chain disruptions and strict government regulations. Desiccant is one of the essential components of the pharmaceutical industry. It helps in reducing moisture content in the medicines to preserve the quality and prolong the medicine’s life. In the early phase of the COVID-19 pandemic, in the year 2020, there was a shortage of pharmaceutical desiccants due to supply chain disruptions in most of the regions. After the first wave of COVID-19, various governments took action to normalize the supply chain of pharmaceutical products. The demand for pharmaceutical desiccants increased during this period for various pharmaceutical applications. It is being used in COVID-19 test kits to help test kits remain effective during shipping to and from laboratories. For instance, companies like Abott Laboratories use desiccants for their Covid-19 rapid identification testing, which can reveal results within five minutes. Thus, COVID-19 has a positive impact on the global pharmaceutical desiccants market.


The COVID-19 pandemic has disrupted the supply chain and interrupted the entire value chain of the pharmaceutical desiccants market, from raw material procurement to manufacturing, packaging, and distribution. On the distribution front, the impact has not been very severe as online pharmacies could solve supply constraints of hospital and retail pharmacies to an extent. However, as the number of COVID-19 cases declines and trade barriers are lifted, the supply chain is expected to return to normalcy soon.


Market Dynamics


Drivers


  • Expanding Pharmaceutical Industry


The pharmaceutical industry plays a dynamic role in developing vaccines & medications to reduce the risks and treat severe diseases and simultaneously improve the personal satisfaction of individuals. The industry has a key contribution to developing technologically advanced products through imaginative research to meet the growing demand. Globally, pharmaceutical services have become one of the fastest-growing segments—both in terms of income and business.


Restraints


  • Stringent regulations and high cost of the finished product


Pharmaceutical packaging supports protecting the medicines from contamination, damage, degradation, and counterfeiting. The desiccant products have to show consistency in their manufacturing and technical performance before it is used in pharmaceutical products. Additionally, due to the high quality of packaging for protecting pharmaceutical products from external impurities and keeping products bacteria-free for a long duration, the relative cost of the final finished product has increased multiple times. Thus, the high cost of the finished product is expected to be the major factor hampering the growth of the global pharmaceutical desiccants market.


Opportunity


  • Increasing Demand for Pharmaceutical Desiccants in Emerging Economies


Developing nations such as India, China, Brazil, Russia, and Turkey present numerous opportunities for the pharmaceutical desiccants market. In India, there is an increase in the development of small and large pharmaceutical packaging companies, which provide an opportunity for desiccant manufacturers to manufacture high-quality products for different applications. In addition, there is an increase in the awareness of the benefits of desiccants, due to which their demand has increased. This has led to an increase in the production of pharmaceutical desiccants in the country.


Challenges


  • Rising Customer Expectations in the Indian Market


The pricing of the drugs takes into account the average of all the drugs with a market share of 1% or more. The government contribution to the healthcare sector is 2.1% of GDP as of 2020, making it difficult for the pharmaceutical company to cater to those below the poverty line. The pharmaceutical industry is expected to adopt market-based pricing rather than cost-based pricing, which would reduce overall costs. The rising customer expectations for better medicines is the major challenge that hinders the growth of the pharmaceutical industry. Customers, physicians, and patients demand higher quality drugs along with novel therapies which are economically better than the existing ones


Segmentation


By Type



  • Silica Gel

  • Activated

  • Carbonclay Desiccant

  • Molecular Sieves


By End-Use



  • Tablets

  • API’s

  • Capsules

  • Nutraceutical Product Packaging


Regional Analysis


The countries of the US and Canada form the market for pharmaceutical desiccant in the North American region. The US FDA is regarded as one of the best regulatory bodies in the world. Product approvals are quick, with a median time of approximately 13 months. On the other hand, the country's free pricing policy is a major benefit to the pharmaceutical desiccant industry. Additionally, the strong pharmaceutical manufacturing base in the region, due to supportive government regulations and high R&D expenditure, bodes drives the growth of the market. The increasing growth of the pharmaceutical industry in the European region is influenced by the growth of the pharmaceutical desiccants market. The rising disposable incomes and economic gains have mainly contributed to the rapid growth of the pharmaceutical market. The increase in income levels, especially for people belonging to the lower economic strata, along with initiatives by the government to provide basic healthcare facilities are expected to increase the availability and affordability of medicines for the population.


China, Japan, India, South Korea, and countries in rest of APAC together form the pharmaceutical desiccants market for the Asia-Pacific region. The growth in the geriatric population leads to an increase in the cases of diseases and more requirements of healthcare facilities for the population. Thus, there will be a growth in the use of medical facilities and healthcare products, which will lead to an increase in pharmaceutical desiccant production. Brazil, Mexico and countries in rest of Latin America together form the market for pharmaceutical desiccant in the Latin American region. The pharmaceutical products must meet stringent quality control & performance criteria in the Latin American regions. Suppliers and manufacturers of desiccants have to meet the quality management system by pharmaceutical companies on a regular basis.


Competitive Landscape


The global pharmaceutical desiccants market is expected to showcase healthy growth throughout the forecast period. The global market represents strong numbers in terms of consumption and is expected to grow year on year. The global pharmaceutical desiccants market is highly fragmented, with a majority presence of tier-1 players. Some of the key players operating in the global pharmaceutical desiccants market are DuPont de Nemours, Inc., Filtration Group Corporation, Sanner GmBH, Clariant, CSP Technologies, Inc., Capitol Scientific, Inc., Desiccare, Inc., W. R. Grace & Co., Desican Inc., and Oker-Chemie GmbH.


Some of the key developments include:



  • I. Du Pont de Nemours and Company and Filtration Group Corporation are planning to launch advanced technologies and materials to gain higher market value.

  • CSP Technologies, Inc and W.R. Grace & Co are investing in research and development to introduce innovative desiccants in the market.


Report Overview:


The pharmaceutical desiccants market is segmented by type, end-use, and region in the report. In terms of insights, this report has focused on various levels of analysis such as market dynamics, value chain analysis, Porter's five forces, competitive landscape, and company profiles—all of which comprise and discuss views on the global pharmaceutical desiccants emerging and fast-growing segments, regions, and countries.


Objectives of the Study



  • To get a comprehensive overview of the global pharmaceutical desiccants market

  • To get wide-ranging information about the key factors driving the market and market opportunities

  • To gain information regarding the key players in the industry, their product portfolio, strategies, and key developments

  • To gain insights about the key country/region in which the market is growing


Intended Audience



  • Pharmaceutical Desiccants Companies

  • Pharmaceutical Companies

  • Packaging Companies

  • Research Institutes

  • Academic Institutes

  • Government Organizations



Report Scope:
Report Attribute/Metric Details
  Market Size    2030: USD 144,840.70 Thousand
  CAGR    4.77% CAGR (2021-2030)
  Base Year   2020
  Forecast Period   2021-2030
  Historical Data    2019
  Forecast Units   Value (USD Thousand) & Volume (Tons)
  Report Coverage   Revenue Forecast, Competitive Landscape, and Growth Factors
  Segments Covered    Type and End-Use
  Geographies Covered   North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa
  Key Vendors   DuPont de Nemours, Inc., Filtration Group Corporation, Sanner GmBH, Clariant, CSP Technologies, Inc., Capitol Scientific, Inc., Desiccare, Inc., W. R. Grace & Co., Desican Inc., and Oker-Chemie GmbH
  Key Market Opportunities   β€’ Increasing Demand for Pharmaceutical Desiccants in Emerging Economies
  Key Market Drivers   β€’ Expanding Pharmaceutical Industry β€’ Growing Geriatric Population Across the Globe


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

The global pharmaceutical desiccants market would register a growth of 4.77%.

The silica gel will play a prominent role in taking the market forward.

Stringent regulations and high cost of the finished products could restrain the market.

North America would enjoy the upper hand in the pharmaceutical desiccants market.